Anti-tumour necrosis factor specific antibody (infliximab) treatment provides insights into the pathophysiology of rheumatoid arthritis.

Bibliographic Details
Main Authors:	Maini, R, Taylor, P, Paleolog, E, Charles, P, Ballara, S, Brennan, F, Feldmann, M
Format:	Journal article
Language:	English
Published:	1999

Similar Items